BioPharmaChem Impact 2026 brings together 430 delegates as the sector surpasses €139 billion in annual exports
BioPharmaChem Impact 2026 brings together 430 delegates as the sector surpasses €139 billion in annual exports
BioPharmaChem Impact 2026 opens today in Dublin as the BioPharmaChem sector operates from a position of record strength, with annual exports now surpassing €139 billion. The sector brings together 430 senior representatives from across industry and government to set out a strategic roadmap ahead of Ireland’s EU Council Presidency.
The conference, co-hosted by BioPharmaChem Ireland alongside Enterprise Ireland and IDA Ireland, focuses on the industry’s transition toward next-generation manufacturing, with a focus on the future of biologics and active pharmaceuticals Ingredients. The event marks an industry-wide shift toward using AI to speed up drug production and a coordinated effort to secure global supply chains against macro-political volatility.
Dr Sinead Keogh, Head of Sectors at Ibec and Director of BioPharmaChem Ireland: “Today we celebrate the resilience of a sector navigating a complex geopolitical climate. As Ireland prepares for the EU Presidency in July, we have an opportunity to move European legislation from high-level ambition into tangible action. By advocating for an EU Biotech Act and a Critical Medicines Act, we are calling for a legislative environment that reinforces Europe’s global leadership while ensuring Ireland remains the frontier for pharmaceutical innovation.”
Cepta Duffy, Head of Lifescience and Healthtech at Enterprise Ireland, said: “The innovation and global focus on display today at BioPharmaChem Impact 2026 reflects the strength of the ecosystem driving Ireland’s lifesciences sector forward. Enterprise Ireland is focused on supporting Irish companies to compete across the global biopharma value chain. By fostering stronger and nurturing industry-academia collaboration, we are ensuring our innovative firms have a strong foundation in place to scale and lead on the international stage.”
Rory Mullen, Head of BioPharma & Food at IDA Ireland, said: “Ireland’s position as a location for high-value manufacturing and investment is underpinned by advanced capabilities and world-class talent. As we approach the 2026 Presidency, IDA Ireland is committed to supporting the sector’s evolution in areas such as digitalisation and sustainability. Maintaining our reputation as a 'Pillar of Trust' ensures Ireland continues to attract the next generation of complex life sciences investment.”
BioPharmaChem Ireland extends its sincere thanks to the BioPharmaChem Impact 2026 sponsors, including Platinum sponsors Chemco Ireland, Frontier Scientific Solutions, and WuXi Biologics; Gold sponsors BioPharmaChem Skillnet, Brightbeam, Camida, DHL, EY, Indaver, PMTC, and SkyCell; and Silver sponsors Innopharma Education, LSC, Life Science Recruitment, Ibec Laboratory Apprenticeship, Micro Bio, and National Chemical Company.
